Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1193Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
READING BETWEEN THE LINES
Year : 2020  |  Volume : 11  |  Issue : 1  |  Page : 44-46

CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with T2D trial


Department of Medical, Eris Lifesciences Limited, Ahmedabad, Gujarat, India

Correspondence Address:
Ms. Baishali Nath
Eris Lifesciences Limited, 8th Floor, Commerce House IV, Prahladnagar, Ahmedabad - 380 015,Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/picr.PICR_157_19

Rights and Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2517    
    Printed79    
    Emailed0    
    PDF Downloaded325    
    Comments [Add]    
    Cited by others 2    

Recommend this journal